Journal
INTERNATIONAL IMMUNOLOGY
Volume 19, Issue 7, Pages 813-824Publisher
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxm057
Keywords
-
Categories
Ask authors/readers for more resources
Programmed cell death-1 (PD-1, Pdcd1), an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L-2. Because of the wide range of ligand distribution in the body, its biological significance pervades almost every aspect of immune responses including autoimmunity, tumor immunity, infectious immunity, transplantation immunity, allergy and immunological privilege. In this review, we would like to summarize the history of PDA research since its discovery and recent findings that suggest promising future for the clinical application of PDA agonists and antagonists to various human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available